Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity - Kaneko, M K; Yamada, S; Nakamura, T (Cancer Med, 2017)
, et al.